Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
Entrada Therapeutics announces that an independent DMC recommends initiation of Cohort 3 at the dose of 15 mg/kg in the ELEVATE-45-201 study.